Hemophilia A Drug Market

List of Tables
Table 1. Key Players of Hemophilia A Drug in Global Market
Table 2. Top Hemophilia A Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Hemophilia A Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Hemophilia A Drug Revenue Share by Companies, 2017-2022
Table 5. Global Hemophilia A Drug Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Hemophilia A Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Hemophilia A Drug Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Hemophilia A Drug Product Type
Table 9. List of Global Tier 1 Hemophilia A Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemophilia A Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hemophilia A Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Hemophilia A Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Hemophilia A Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Hemophilia A Drug Sales (K Pcs), 2017-2022
Table 15. By Type - Global Hemophilia A Drug Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Hemophilia A Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Hemophilia A Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Hemophilia A Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Hemophilia A Drug Sales (K Pcs), 2017-2022
Table 20. By Application - Global Hemophilia A Drug Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Hemophilia A Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Hemophilia A Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Hemophilia A Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Hemophilia A Drug Sales (K Pcs), 2017-2022
Table 25. By Region - Global Hemophilia A Drug Sales (K Pcs), 2023-2028
Table 26. By Country - North America Hemophilia A Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Hemophilia A Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Hemophilia A Drug Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Hemophilia A Drug Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Hemophilia A Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Hemophilia A Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Hemophilia A Drug Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Hemophilia A Drug Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Hemophilia A Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Hemophilia A Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Hemophilia A Drug Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Hemophilia A Drug Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Hemophilia A Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Hemophilia A Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Hemophilia A Drug Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Hemophilia A Drug Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Hemophilia A Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Hemophilia A Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Hemophilia A Drug Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Hemophilia A Drug Sales, (K Pcs), 2023-2028
Table 46. Bayer AG Corporate Summary
Table 47. Bayer AG Hemophilia A Drug Product Offerings
Table 48. Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. BioMarin Pharmaceutical Inc Corporate Summary
Table 50. BioMarin Pharmaceutical Inc Hemophilia A Drug Product Offerings
Table 51. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Bioverativ Inc Corporate Summary
Table 53. Bioverativ Inc Hemophilia A Drug Product Offerings
Table 54. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Catalyst Biosciences Inc Corporate Summary
Table 56. Catalyst Biosciences Inc Hemophilia A Drug Product Offerings
Table 57. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Chugai Pharmaceutical Co Ltd Corporate Summary
Table 59. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Offerings
Table 60. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. CSL Ltd Corporate Summary
Table 62. CSL Ltd Hemophilia A Drug Product Offerings
Table 63. CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. DBV Technologies SA Corporate Summary
Table 65. DBV Technologies SA Hemophilia A Drug Product Offerings
Table 66. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Dimension Therapeutics Inc Corporate Summary
Table 68. Dimension Therapeutics Inc Hemophilia A Drug Product Offerings
Table 69. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. EpiVax Inc Corporate Summary
Table 71. EpiVax Inc Hemophilia A Drug Product Offerings
Table 72. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Expression Therapeutics LLC Corporate Summary
Table 74. Expression Therapeutics LLC Hemophilia A Drug Product Offerings
Table 75. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Green Cross Corp Corporate Summary
Table 77. Green Cross Corp Hemophilia A Drug Product Offerings
Table 78. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Idogen AB Corporate Summary
Table 80. Idogen AB Hemophilia A Drug Product Offerings
Table 81. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Immusoft Corp Corporate Summary
Table 83. Immusoft Corp Hemophilia A Drug Product Offerings
Table 84. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. LFB SA Corporate Summary
Table 86. LFB SA Hemophilia A Drug Product Offerings
Table 87. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. mAbxience SA Corporate Summary
Table 89. mAbxience SA Hemophilia A Drug Product Offerings
Table 90. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Hemophilia A Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 92. Global Hemophilia A Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 93. Global Hemophilia A Drug Production by Region, 2017-2022 (K Pcs)
Table 94. Global Hemophilia A Drug Production by Region, 2023-2028 (K Pcs)
Table 95. Hemophilia A Drug Market Opportunities & Trends in Global Market
Table 96. Hemophilia A Drug Market Drivers in Global Market
Table 97. Hemophilia A Drug Market Restraints in Global Market
Table 98. Hemophilia A Drug Raw Materials
Table 99. Hemophilia A Drug Raw Materials Suppliers in Global Market
Table 100. Typical Hemophilia A Drug Downstream
Table 101. Hemophilia A Drug Downstream Clients in Global Market
Table 102. Hemophilia A Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hemophilia A Drug Segment by Type
Figure 2. Hemophilia A Drug Segment by Application
Figure 3. Global Hemophilia A Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hemophilia A Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hemophilia A Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Hemophilia A Drug Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Hemophilia A Drug Revenue in 2021
Figure 9. By Type - Global Hemophilia A Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Hemophilia A Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Hemophilia A Drug Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Hemophilia A Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Hemophilia A Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Hemophilia A Drug Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Hemophilia A Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Hemophilia A Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Hemophilia A Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Hemophilia A Drug Sales Market Share, 2017-2028
Figure 19. US Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Hemophilia A Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Hemophilia A Drug Sales Market Share, 2017-2028
Figure 24. Germany Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Hemophilia A Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Hemophilia A Drug Sales Market Share, 2017-2028
Figure 33. China Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Hemophilia A Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Hemophilia A Drug Sales Market Share, 2017-2028
Figure 40. Brazil Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Hemophilia A Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Hemophilia A Drug Sales Market Share, 2017-2028
Figure 44. Turkey Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Hemophilia A Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Hemophilia A Drug Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Hemophilia A Drug by Region, 2021 VS 2028
Figure 50. Hemophilia A Drug Industry Value Chain
Figure 51. Marketing Channels